Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
- PMID: 22340817
- PMCID: PMC3305584
- DOI: 10.1186/1471-230X-12-16
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome that is closely associated with multiple factors such as obesity, hyperlipidemia and type 2 diabetes mellitus. However, other risk factors for the development of NAFLD are unclear. With the association between periodontal disease and the development of systemic diseases receiving increasing attention recently, we conducted this study to investigate the relationship between NAFLD and infection with Porphyromonas gingivalis (P. gingivalis), a major causative agent of periodontitis.
Methods: The detection frequencies of periodontal bacteria in oral samples collected from 150 biopsy-proven NAFLD patients (102 with non-alcoholic steatohepatitis (NASH) and 48 with non-alcoholic fatty liver (NAFL) patients) and 60 non-NAFLD control subjects were determined. Detection of P. gingivalis and other periodontopathic bacteria were detected by PCR assay. In addition, effect of P. gingivalis-infection on mouse NAFLD model was investigated. To clarify the exact contribution of P. gingivalis-induced periodontitis, non-surgical periodontal treatments were also undertaken for 3 months in 10 NAFLD patients with periodontitis.
Results: The detection frequency of P. gingivalis in NAFLD patients was significantly higher than that in the non-NAFLD control subjects (46.7% vs. 21.7%, odds ratio: 3.16). In addition, the detection frequency of P. gingivalis in NASH patients was markedly higher than that in the non-NAFLD subjects (52.0%, odds ratio: 3.91). Most of the P. gingivalis fimbria detected in the NAFLD patients was of invasive genotypes, especially type II (50.0%). Infection of type II P. gingivalis on NAFLD model of mice accelerated the NAFLD progression. The non-surgical periodontal treatments on NAFLD patients carried out for 3 months ameliorated the liver function parameters, such as the serum levels of AST and ALT.
Conclusions: Infection with high-virulence P. gingivalis might be an additional risk factor for the development/progression of NAFLD/NASH.
Figures
Similar articles
-
Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.J Gastroenterol. 2018 Feb;53(2):269-280. doi: 10.1007/s00535-017-1368-4. Epub 2017 Jul 24. J Gastroenterol. 2018. PMID: 28741270
-
Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.Trials. 2020 Mar 23;21(1):291. doi: 10.1186/s13063-020-4201-y. Trials. 2020. PMID: 32293522 Free PMC article. Clinical Trial.
-
Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.J Gastroenterol. 2013 Nov;48(11):1259-70. doi: 10.1007/s00535-012-0738-1. Epub 2013 Jan 11. J Gastroenterol. 2013. PMID: 23307045
-
Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease.Ann Med. 2023;55(2):2255825. doi: 10.1080/07853890.2023.2255825. Ann Med. 2023. PMID: 37708866 Free PMC article. Review.
-
Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. World J Gastroenterol. 2023. PMID: 36844143 Free PMC article. Review.
Cited by
-
Inhibitory Effects of the Heat-Killed Lactic Acid Bacterium Enterococcus faecalis on the Growth of Porphyromonas gingivalis.Curr Ther Res Clin Exp. 2024 Feb 1;100:100731. doi: 10.1016/j.curtheres.2024.100731. eCollection 2024. Curr Ther Res Clin Exp. 2024. PMID: 38380421 Free PMC article.
-
Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll-like receptor 2 and plasminogen activator inhibitor-1.J Extracell Vesicles. 2024 Jan;13(1):e12407. doi: 10.1002/jev2.12407. J Extracell Vesicles. 2024. PMID: 38251423 Free PMC article.
-
Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis.NPJ Biofilms Microbiomes. 2024 Jan 17;10(1):3. doi: 10.1038/s41522-024-00476-x. NPJ Biofilms Microbiomes. 2024. PMID: 38233485 Free PMC article.
-
Oral Pathogenic Bacteria and the Oral-Gut-Liver Axis: A New Understanding of Chronic Liver Diseases.Diagnostics (Basel). 2023 Oct 26;13(21):3324. doi: 10.3390/diagnostics13213324. Diagnostics (Basel). 2023. PMID: 37958220 Free PMC article. Review.
-
Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from Porphyromonas gingivalis through enhanced hepatic clearance.PLoS One. 2023 Oct 20;18(10):e0291880. doi: 10.1371/journal.pone.0291880. eCollection 2023. PLoS One. 2023. PMID: 37862331 Free PMC article.
References
-
- Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18:1221–1231. - PubMed
-
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. - PubMed
-
- Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40:(Suppl 1):S11–S16. - PubMed
-
- Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1998;95:1056–1062. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
